Calendar Alligator Bioscience AB London S.E.

Equities

Market Closed - London S.E. Other stock markets 15:52:01 17/11/2021 GMT			5-day change	1st Jan Change
2.508 ^SEK	-66.28%		+123.96%	+303.28%

06-14	Alligator Bioscience Names New CFO	MT
06-03	Alligator Bioscience Announces Publication of on Its Lead Drug Candidate Positive Phase 2 Data Mitazalimab in First Line Metastatic Pancreatic Cancer in the Lancet Oncology	CI

a930c09.prVCgXoLsa-3Hk-V1h8vFHOLv6YG12CeSY9M_2hoa_k.199zsihT_97QTibYok9qeDfh6ZFXpSisEboVuxIME8yL0izMAjLI9-gsdw~f12fa216ef500ee57f84610759fc6b1d

11/07/2024 07:00	Q2 2024 Earnings Release
24/10/2024 07:00	Q3 2024 Earnings Release
12/02/2025	Q4 2024 Earnings Release (Projected)
28/04/2025	Q1 2025 Earnings Release (Projected)
09/07/2025	Q2 2025 Earnings Release (Projected)
22/10/2025	Q3 2025 Earnings Release (Projected)

01/06/2024 19:30	American Society of Clinical Oncology Meeting - Abstract No 4133
01/06/2024 15:00	American Society of Clinical Oncology Meeting - Abstract No 2569
07/05/2024 13:00	Annual General Meeting
06/05/2024 14:00	Q1 2024 Earnings Call
06/05/2024 07:00	Q1 2024 Earnings Release
14/03/2024 10:30	Extraordinary Shareholders Meeting
09/02/2024 13:00	Q4 2023 Earnings Call
08/02/2024 07:00	Q4 2023 Earnings Release
29/01/2024 15:00	Mitazalimab OPTIMIZE-1 Phase 2 Study Results Call
24/01/2024 08:15	Redeye Theme: Fight Cancer
01/12/2023 13:00	Capital Markets Day
26/10/2023 11:30	Q3 2023 Earnings Call
26/10/2023 07:00	Q3 2023 Earnings Release
13/07/2023 15:00	Q2 2023 Earnings Call
13/07/2023 07:00	Q2 2023 Earnings Release
09/05/2023	Redeye Medtech Forum
02/05/2023	Annual General Meeting
25/04/2023	Redeye Orphan Drugs Event
25/04/2023 11:30	Q1 2023 Earnings Call
25/04/2023 07:00	Q1 2023 Earnings Release

Fiscal Period	December	2019	2020	2021	2022	2023	2024
Net sales Million SEK	Released Forecast Spread	5,40 2,04 164.94%	6,67 5,90 12.98%	15,1 10,6 42.16%	37,1 25,9 43.36%	61,9 97,1 -36.26%	261
EBITDA Million SEK	Released Forecast Spread	-203 -205 0.82%	-133 -130 -2.29%	-130 -132 1.18%	-181 -176 -3.01%	-238 -160 -48.62%	5,96
EBIT Million SEK	Released Forecast Spread	-215 -211 -1.66%	-144 -142 -1.56%	-142 -143 1.28%	-193 -185 -4.34%	-249 -171 -45.41%	-2,29
Earnings before Tax (EBT) Million SEK	Released Forecast Spread	-210 -210 -0.06%	-143 -141 -1.59%	-142 -143 1.06%	-193 -184 -4.91%	-249 -146 -70.47%	-6,11
Net income Million SEK	Released Forecast Spread	-210 -210 -0.06%	-143 -141 -1.59%	-142 -143 1.08%	-193 -184 -4.91%	-249 -171 -45.76%	-6,11
EPS SEK	Released Forecast Spread	-2,94 -2,94 0.03%	-2,01 -1,98 -1.75%	-0,64 -1,63 60.82%	-0,88 -0,81 -8.96%	-0,55 -0,29 -88.81%	-0,46
Announcement Date		12/02/20	26/02/21	11/02/22	10/02/23	08/02/24	-

15/07/2024 06:45	ADDLIFE AB: Q2 2024 Earnings Release
21/07/2024	MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
23/07/2024	SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected)
23/07/2024	ALKERMES PLC: Q2 2024 Earnings Release (Projected)
23/07/2024	IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected)
23/07/2024	ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected)
24/07/2024	LONZA GROUP AG: Q2 2024 Earnings Release
25/07/2024 06:00	BACHEM HOLDING AG: Q2 2024 Earnings Release
25/07/2024	PHARVARIS N.V.: Q2 2024 Earnings Release (Projected)
26/07/2024 06:00	BB BIOTECH AG: Q2 2024 Earnings Release

29/05/2024 21:01	IMMUNOVANT, INC.: Q4 2024 Earnings Release
23/05/2024 12:00	CUREVAC N.V.: Q1 2024 Earnings Release
22/05/2024 06:00	EVOTEC SE: Q1 2024 Earnings Release
21/05/2024 22:14	ALVOTECH: Q1 2024 Earnings Release
21/05/2024 12:00	EXSCIENTIA PLC: Q1 2024 Earnings Release
17/05/2024 07:00	BIOARCTIC AB: Q1 2024 Earnings Release
15/05/2024 21:05	CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release
15/05/2024 12:00	PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release
14/05/2024	GNI GROUP LTD.: Q1 2024 Earnings Release
14/05/2024 21:05	KYVERNA THERAPEUTICS, INC.: Q1 2024 Earnings Release